Pértega-Gomes, N., Vízcaíno, R., Gonçalves, V. M., Pinheiro, C., Silva, J., Pereira, H., . . . Baltazar, F. (2011). Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
Chicago Style (17th ed.) CitationPértega-Gomes, Nelma, et al. Monocarboxylate Transporter 4 (MCT4) and CD147 Overexpression Is Associated with Poor Prognosis in Prostate Cancer. 2011.
MLA (8th ed.) CitationPértega-Gomes, Nelma, et al. Monocarboxylate Transporter 4 (MCT4) and CD147 Overexpression Is Associated with Poor Prognosis in Prostate Cancer. 2011.
Warning: These citations may not always be 100% accurate.